To Evaluate the Efficacy and Safety in Patients With Dyslipidemia and Hypertension
Status:
Recruiting
Trial end date:
2023-03-31
Target enrollment:
Participant gender:
Summary
A Multi-center, Randomized, Double-blind, Parallel, phase III Clinical Trial to Evaluate the
Efficacy and Safety of Co-administration of JW0101+C2101 in Patients with Dyslipidemia and
Hypertension.